In this issue:
Does IA triamcinolone relieve knee OA pain?
SC belimumab in moderate to severe SLE
Early TNFi therapy restores work ability for RA patients
Secukinumab: high 2-year response rates in AS
Premature mortality persists in gout
Defining remission in RA from the patient’s perspective
Celecoxib vs naproxen for reducing recurrent GI bleeding on NSAID+aspirin
Closing the mortality gap in RA
Pharmaco-economic aspects of TNFi for RA
Comparing TNFi eligibility in RA patients in the real world vs RCTs
Please login below to download this issue (PDF)